Closely-held Ondine Biomedical appointed Cameron Lawrence as chief operating officer and chief financial officer.
Mr. Lawrence previously served in positions of increasing responsibility, including CFO and later general manager and CEO of PNI Digital Media, prior to its acquisition by Staples in 2013. Prior to PNI, he served as principal financial officer of OncoGenex Pharmaceuticals, a publicly traded biopharmaceutical company.
In a statement, Carolyn Cross, Ondine’s chairman and CEO, said Mr. Lawrence brings extensive operational and financial expertise to Ondine as the company continues its trajectory as a growing biomedical company
Mr. Lawrence said Ondine is uniquely positioned to address unmet patient needs in both the infection control and chronic sinusitis markets.